Science
Mechanism of Action
This ingredient functions as both a ceramide analog and a GPR119 agonist. It has been shown in in vitro models to stimulate the skin's natural synthesis of long-chain ceramides, specifically those with C22-C24 fatty acids, through a CB1-dependent pathway. This action is crucial for fortifying the epidermal permeability barrier. Additionally, the oleamide component acts as an agonist for cannabinoid 1 (CB1) receptors and activates the TRPV1 vanilloid receptor, contributing to cannabinoid-like effects and potential vasodilation. It may also enhance endocannabinoid activity by inhibiting FAAH-mediated hydrolysis, thereby providing robust skin protection from external environmental factors.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
The serinol backbone is reported to be very stable, though it is also described as corrosive and hygroscopic, and dissolves well in water. However, specific stability data for the compounded Oleamide Serinol are not explicitly available.
Safety
Safety Profile
No specific Cosmetic Ingredient Review (CIR) or Scientific Committee on Consumer Safety (SCCS) assessment has been conducted directly for Oleamide Serinol. While its constituent, Oleamide, has been shown to be non-hazardous and caused no skin or eye irritation in animal and human patch tests, direct safety data for Oleamide Serinol in cosmetic applications remains unreviewed by these bodies.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Oleamide Serinol demonstrates a promising mechanistic profile for strengthening the skin barrier by stimulating ceramide production; however, comprehensive direct human clinical efficacy studies for this specific compound are currently limited, necessitating further research to establish its precise topical benefits.
Related
Similar Ingredients
Finding similar ingredients…